A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

Uterine cancer is one of the few cancers with increasing mortality; since the mid-2000s the death rate has risen by 1.7% per year. Black women are more likely to die from it. There are more than ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...

Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...

Endometrial cancer originates in the endometrium ... assessed progression-free survival based on the Response Evaluation Criteria in Solid Tumours v1.1 and OS. At the two-and-a-half-year mark, the ...

Major question we raise here – which group of patients is the most favorable to achieve durable immunotherapy response in endometrial cancer? Table 1. Efficacy of immune checkpoint therapy in ...